HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of continuous subcutaneous insulin infusion treatment and multiple daily injection treatment on the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.

Abstract
To evaluate whether continuous subcutaneous insulin infusion attenuates the progression of diabetic complications, we retrospectively extracted data from 35 individuals who had developed type 1 diabetes mellitus aged ≤20 years and whose treatment had been changed from multiple daily injections to continuous subcutaneous insulin infusion. The annual changes in estimated glomerular filtration rate, urinary albumin excretion rate, carotid intima-media thickness and brachial-ankle pulse wave velocity during each treatment period were calculated. Although mean glycated hemoglobin under the continuous subcutaneous insulin infusion treatment was lower than that under the multiple daily injection treatment, there were no significant differences in annual changes in diabetic nephropathy and atherosclerosis between the two treatment periods. This pilot study showed that, in Japanese patients with juvenile-onset type 1 diabetes mellitus, there was no significant difference in the progression of diabetic nephropathy and atherosclerosis, at least in the early stage, between the two treatments.
AuthorsTakafumi Masuda, Naoto Katakami, Naohiro Taya, Kazuyuki Miyashita, Mitsuyoshi Takahara, Ken Kato, Akio Kuroda, Munehide Matsuhisa, Iichiro Shimomura
JournalJournal of diabetes investigation (J Diabetes Investig) Vol. 13 Issue 9 Pg. 1528-1532 (Sep 2022) ISSN: 2040-1124 [Electronic] Japan
PMID35474612 (Publication Type: Journal Article)
Copyright© 2022 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.
Chemical References
  • Glycated Hemoglobin A
  • Insulin
Topics
  • Ankle Brachial Index
  • Atherosclerosis (etiology)
  • Carotid Intima-Media Thickness
  • Diabetes Complications (etiology)
  • Diabetes Mellitus, Type 1 (complications, drug therapy)
  • Diabetic Nephropathies (etiology)
  • Glycated Hemoglobin (analysis)
  • Humans
  • Injections, Subcutaneous
  • Insulin (therapeutic use)
  • Insulin Infusion Systems
  • Japan (epidemiology)
  • Pilot Projects
  • Pulse Wave Analysis
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: